相关实验视频

Updated: Sep 17, 2025

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis

Published on: June 27, 2020

肝细胞癌中的融合转录景观以及对融合伙伴表达的潜在影响

Yasemin Öztemur Islakoğlu¹, Peyda Korhan^1,2,3, Leman Binokay^1,4

¹İzmir Biomedicine and Genome Center, İzmir, Turkey.

|July 4, 2025

概括

这项研究在肝细胞癌 (HCC) 中确定了15种新的瘤特异性融合转录 (FT),其中SERPINA1-H19是最常见的. 这些FT及其改变的基因表达具有作为HCC的诊断和预后生物标志物的潜力.

科学领域:

在瘤学瘤学.
基因组学就是基因组学.
分子生物学分子生物学

背景情况:

融合转录 (FT) 是由染色体重排或转录事件引起的RNA分子,涉及到瘤发生.
肝细胞癌 (HCC) 是一个重要的全球健康问题,需要改进诊断和预后工具.

研究的目的:

系统地识别和描述HCC中的瘤特异性FT.
研究FT在肝癌发生中的作用及其作为生物标志物的潜力.

主要方法:

利用来自独立数据集和癌症基因组图谱 (TCGA) 的高通量RNA测序数据进行元队列分析 (328个HCC样本).
雇佣了STAR-Fusion来识别新型的FT.
使用in silico (436个TCGA样本) 和湿实验室队列 (42个样本) 的验证结果.

主要成果:

在HCC中确定了15种新的瘤特异性FT,其中SERPINA1-H19是最常见的.
与正常的邻近肝脏组织 (NAT) 相比,在HCC瘤中观察到融合伙伴基因的显著下调.
发现关键的肝脏相关基因 (例如,ALB,APOA2,IGF2,MT2A,SERPINA1,H19) 经常参与FT,这表明肝癌发生的功能改变. 低SERPINA1和H19的表达与激进的HCC表型相关.

结论:

这项研究提供了HCC中首个全面的FT存储库.
已识别的FT,特别是SERPINA1-H19,以及它们相关的基因表达模式,作为HCC的诊断和预后生物标志物具有前途.
涉及关键肝脏基因的FT可能在HCC发育中发挥关键作用.

关键词:

核聚变的成绩单转录 H19 H19 是一种H19病毒.在RNA-seqqq.塞尔皮纳 (SERPINA) 是一个名字.生物标志物生物标志物肝细胞癌是肝细胞癌.

更多相关视频

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing

Published on: July 5, 2019

Targeted RNA Sequencing Assay to Characterize Gene Expression and Genomic Alterations

Targeted RNA Sequencing Assay to Characterize Gene Expression and Genomic Alterations

Published on: August 4, 2016

相关概念视频

General Transcription Factors

General Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...